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The African Genome Variation Project
shapes medical genetics in Africa
Deepti Gurdasani1,2*, Tommy Carstensen1,2*, Fasil Tekola-Ayele3*, Luca Pagani1,4*, Ioanna Tachmazidou1*,
Konstantinos Hatzikotoulas1, Savita Karthikeyan1,2, Louise Iles1,2,5, Martin O. Pollard1, Ananyo Choudhury6,
GrahamR. S. Ritchie1,7, Yali Xue1, JenniferAsimit1, RebeccaN.Nsubuga8, ElizabethH.Young1,2, Cristina Pomilla1,2, Katja Kivinen1,
Kirk Rockett9, Anatoli Kamali8, Ayo P. Doumatey3, Gershim Asiki8, Janet Seeley8, Fatoumatta Sisay-Joof10, Muminatou Jallow10,
Stephen Tollman11,12, Ephrem Mekonnen13, Rosemary Ekong14, Tamiru Oljira15, Neil Bradman16, Kalifa Bojang10,
Michele Ramsay6,17,18, Adebowale Adeyemo3, Endashaw Bekele19, Ayesha Motala20, Shane A. Norris21, Fraser Pirie20,
Pontiano Kaleebu8, Dominic Kwiatkowski1,9, Chris Tyler-Smith11, Charles Rotimi31, Eleftheria Zeggini11
& Manjinder S. Sandhu1,21
Given the importance ofAfrica to studies of humanorigins anddisease susceptibility, detailed characterization ofAfrican
genetic diversity is needed. The African Genome Variation Project provides a resource with which to design, implement
and interpret genomic studies in sub-Saharan Africa and worldwide. The African Genome Variation Project represents
dense genotypes from 1,481 individuals and whole-genome sequences from 320 individuals across sub-Saharan Africa.
Using this resource, we find novel evidence of complex, regionally distinct hunter-gatherer and Eurasian admixture
across sub-Saharan Africa. We identify new loci under selection, including loci related to malaria susceptibility and
hypertension.We show that modern imputation panels (sets of reference genotypes fromwhich unobserved ormissing
genotypes in study sets can be inferred) can identify association signals at highly differentiated loci across populations in
sub-Saharan Africa. Using whole-genome sequencing, we demonstrate further improvements in imputation accuracy,
strengthening the case for large-scale sequencing efforts of diverse African haplotypes. Finally, we present an efficient
genotype array design capturing common genetic variation in Africa.
Globally, human populations show structured genetic diversity as a
result of geographical dispersion, selection and drift. Understanding
this variation can provide insights into evolutionary processes that
shape both human adaptation and variation in disease susceptibility1.
Although the Hapmap Project2 and the 1000 Genomes Project3 have
greatly enhanced our understanding of genetic variation globally, the
characterization of African populations remains limited. Other efforts
examiningAfricangenetic diversityhavebeen limitedbyvariant density
and sample sizes in individual populations4, or have focused on isolated
groups, such as hunter gatherers (HG)5,6, limiting relevance to more
widespread populations across Africa.
The African Genome Variation Project (AGVP) is an international
collaboration that expands on these efforts by systematically assessing
geneticdiversity among1,481 individuals from18ethno-linguistic groups
from sub-Saharan Africa (SSA) (Fig. 1 and Supplementary Methods
Tables 1 and2)with theHumanOmni2.5Mgenotyping array andwhole-
genome sequences (WGS) from 320 individuals (Supplementary
MethodsTable 2). Importantly, theAGVPhas evolved to help develop
local resources for public health andgenomic research, including strength-
ening research capacity, training, and collaboration across the region.
We envisage that data from this project will provide a global resource
for researchers, as well as facilitate genetic studies in Africa7.
Population structure in SSA
On examining,2.2million variants, we foundmodest differentiation
among SSA populations (mean pairwise FST 0.019) (Supplementary
Methods andSupplementaryTable1).Differentiationamong theNiger-
Congo language groups—the predominant linguistic grouping across
Africawas noted to bemodest (mean pairwiseFST 0.009) (Supplemen-
tary Table 1), providing evidence for the ‘Bantu expansion’—a recent
population expansion and movement throughout SSA originating in
West Africa around 3,000 to 5,000 years ago8.
We identified 29.8million single-nucleotide polymorphisms (SNPs)
from Ethiopian, Zulu and BagandanWGS (Extended Data Fig. 1 and
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SupplementaryMethods). A substantial proportion of unshared (11%–
23%) and novel (16%–24%) variants were observed, with the highest
proportion among Ethiopian populations (Extended Data Fig. 1). The
highproportion of unshared variation among populations recapitulates
the need for large-scale sequencing across Africa, including among ge-
netically divergent populations.
Weusedprincipal component analysis to explore relationships among
AGVPpopulations (ExtendedDataFigs2–5, SupplementaryFigs1and2).
PC1appeared to represent a cline extending fromWest andEastAfrican
populations towards Ethiopian populations, possibly suggesting Eur-
asian gene flow,while PC2 separatedWestAfrican andSouth/EastAfri-
can populations (ExtendedData Fig. 2). Inclusion of the 1000Genomes
Project,NorthAfrican andKhoe-San (Khoisan) populations inprincipal
component analysis (ExtendedData Figs 3–5, and Supplementary Figs 1
and 2) suggested possible HG ancestry among southern Niger-Congo
groups—highlighted by clustering towards the Khoe-San, in addition
to confirming a cline towards Eurasian populations. ‘Unsupervised’
(that is, without including known information on individual ancestry)
ADMIXTURE9 (https://www.genetics.ucla.edu/software/admixture/)
analysis including the 1000Genomes Project andHumanOrigins data
sets (Fig. 1), also supported evidence for substantial Eurasian and HG
ancestry in SSA (Fig. 1 and Extended Data Fig. 6).
To assess the effect of gene flow on population differentiation in
SSA, wemasked Eurasian ancestry across the genome (Supplementary
Methods andSupplementaryNote6).Thismarkedly reducedpopulation
differentiation, asmeasuredbyadecline inmeanpairwiseFST from0.021
to 0.015 (Supplementary Note 6), suggests that Eurasian ancestry has
a substantial impact on differentiation among SSA populations. We
speculate that residual differentiation between Ethiopian and other SSA
populations aftermaskingEurasian ancestry (pairwiseFST5 0.027)may
be a remnant of East African diversity pre-dating the Bantu expansion10.
Population admixture in SSA
Formal tests for admixture (the three population test or f3 statistic)11,
confirmedwidespreadEurasian andHGadmixture in SSA (Supplemen-
taryTables 2 and3).Quantificationof admixture (SupplementaryTable 4,
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Figure 1 | Populations studied in the AGVP. a, 18 African populations
studied in the AGVP including 2 populations from the 1000 Genomes Project.
(The term ‘Ethiopia’ encompasses the Oromo, Amhara and Somali ethno-
linguistic groups.) b, c, ADMIXTURE analysis of these 18 populations alone
(n5 1,481) (b) and in a global context (n5 3,904) (c). Each colour represents a
different ancestral cluster, with clusters 2–6 represented along the y-axis in b
and clusters 2–18 represented in c. K5 6 and K5 18 were the most likely
clusters on ADMIXTURE analysis. ADMIXTURE analysis suggests
substructure between North, East, West and South Africa. Studying these
populations in the context of Eurasian and African HG populations suggest
extensive Eurasian and HG admixture across Africa.
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Supplementary Methods and Supplementary Notes 3 and 4) indicated
substantial Eurasian ancestry inmanyAfricanpopulations (ranging from
0% to 50%),with the greatest proportion in EastAfrica (Fig. 2 and Sup-
plementary Table 4). Similarly, HG admixture ranged from0% to 23%,
beinggreatest amongZulu andSotho (Fig. 2 andSupplementaryTable5).
We found evidence for historically complex and regionally distinct
admixturewithmultipleHGandEurasianpopulations across SSA (Fig. 2
and Supplementary Note 5). Specifically, ancient Eurasian admixture
was observed in central West African populations (Yoruba;,7,500–
10,500 years ago), oldadmixture amongEthiopianpopulations (,2,400–
3,200 years ago) consistent with previous reports10,12, andmore recent
complexadmixture in someEastAfricanpopulations (,150–1,500 years
ago) (Fig. 2, ExtendedDataFig. 7 and SupplementaryNote5).Our find-
ing of ancient Eurasian admixture corroborates findings of non-zero
Neanderthal ancestry inYoruba,which is likely tohavebeen introduced
through Eurasian admixture and back migration, possibly facilitated
by greening of the Sahara desert during this period13,14.
Wealso findevidence for complex and regionallydistinctHGadmix-
ture across SSA (Fig. 2, ExtendedData Figs 7 andSupplementaryNote 5),
with ancient gene flow (,9,000 years ago) among Igboandmore recent
admixture in East and South Africa (multiple events ranging from
100 years ago to3,000 years ago), broadly consistentwithhistoricalmove-
ments reflecting the Bantu expansion. An exploration of the likeliest
sources of admixture in our data suggested that HG admixture in Igbo
was most closely represented by modern day Khoe-San populations
rather than by rainforest HG populations (Supplementary Note 5).
Given limited archaeological and linguistic evidence for the presence
of Khoe-San populations in West Africa, this extant HG admixture
might represent ancient populations, consistent with the presence of
mass HG graves from the early Holocene period comprising skeletons
with distinct morphological features15, and with evidence of HG rock
art dating to this period in the western Sahara16,17. In East Africa, our
analyses suggested thatMbuti rainforest HG populationsmost closely
represented ancient HGmixing populations (Supplementary Note 5),
with admixturedating to,3,000 years ago, suggesting thatHGancestry
here is likely to be older thanpreviously reported18. The primary source
of HG admixture in Zulu and Sotho populations was from Khoe-San
populations (Fig. 2 and Supplementary Note 5), consistent with lin-
guistic assimilation of click consonants among these populations.
Positive selection in SSA
Weexaminedhighly differentiated SNPsbetweenEuropeanandAfrican
populations, as well as amongAfrican populations to gain insights into
loci that may have undergone selection in response to local adaptive
forces (Supplementary Methods). To account for confounding due to
Eurasianadmixture,we also conducted analyses aftermaskingEurasian
ancestry (Supplementary Methods and Supplementary Note 6).
On examining locus-specific Europe–Africa differentiation, enrich-
ment of loci known to be under positive selectionwas observed among
themost differentiated sites (P5 1.43 10231). Furthermore, therewas
statistically significant enrichment for gene variants among these, indi-
cating that this differentiation is unlikely to have arisen purely from
randomdrift (P5 0.0002).Additionally,we foundno evidence forback-
ground selection as the primary driver of differentiation among these
loci (Supplementary Note 7).
In addition to genes known to be under positive selection (for exam-
ple, SLC24A5, SLC45A2 andOCA219,20,LARGE21 andCYP3A4/5) (Sup-
plementary Fig. 3), we found evidence of differentiation in novel gene
regions, including one implicated inmalaria (for chemokine receptor 1,
CR1) (Extended Data Fig. 8). CR1 carries the Knops blood group anti-
gens and has previously been implicated inmalaria susceptibility22 and
severity23,with evidence suggestingpositive selection inmalaria-endemic
regions24 (ExtendedDataFig. 8).We also identifiedhighly differentiated
variants within genes involved in osmoregulation (ATP1A1 andAQP2)
(Extended Data Fig. 8). Deregulation ofAQP2 expression and loss-of-
functionmutations inATP1A1 have been associatedwith essential and
secondary hypertension, respectively25,26. Climatic adaptive changes in
these gene regions could potentially provide a biological basis for the
high burdenof hypertension anddifferences in salt sensitivity observed
in SSA27.
In contrast, overall differentiation among African populations was
modest (maximummaskedFST5 0.19) (SupplementaryFig. 4) andonly
56/1,237 sites remained in the tail distributionaftermasking (Supplemen-
tary Methods, Supplementary Table 6). This suggests that a large pro-
portion of differentiation observed among African populations could
be due to Eurasian admixture, rather than adaptation to selective forces
(SupplementaryNote 6). Genes known to be under selectionwere nota-
bly enriched among the most differentiated loci after masking of Eur-
asian ancestry (P5 2.33 10216). Among the 56 loci robust toEurasian
ancestry masking (Supplementary Table 6), we identified several loci
known to be under selection (Extended Data Fig. 8), including a highly
differentiated variant (rs1378940) in theCSK gene region implicated in
hypertension ingenome-wide association studies (GWAS)28. Themajor
allele of rs1378940 among Africans was in complete linkage disequilib-
riumwith the risk allele of the GWAS SNP rs1378942 (ref. 29), with the
frequency of this allele highly correlated with latitude (r520.67), pro-
viding support for local adaptation in response to temperature as a pos-
sible mechanism for hypertension (Supplementary Fig. 5)30,31.
Comparing populations residing in endemic andnon-endemic infec-
tious disease regions (Supplementary Methods), we identified several
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Figure 2 | Dating and proportion of Eurasian and HG admixture among
African populations. The proportion and distribution of Eurasian and
HG admixture among different populations across Africa, with approximate
dating of admixture using MALDER (code was provided by J. Pickrell; see
Supplementary Information).
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loci associatedwith infectious disease susceptibility and severity.Aswell
as the known sickle-cell locus related to malaria, this approach iden-
tified additional signals for genes potentially under selection, including
thePKLR region32,RUNX333, the haptoglobin locus,CD16334, IL1035,36,
CFH, and the CD28-ICOS-CLTA4 locus (Supplementary Table 7 and
Extended Data Fig. 8)37. Similar comparisons for Lassa fever identified
the knownLARGEgene, aswell as candidates associatedwith viral entry
and immune response, including in the Histocompatibility Leukocyte
Antigen region,DC-SIGN/DC-SIGNR38 (alsoknownasCD209/CLEC4M),
RNASEL,CXCR6, IFIH139 andOAS2/3 regions (SupplementaryTable 7).
For trypanosomiasis, we identifiedAPOL140, as well as several loci im-
plicated in immune response and binding to trypanosoma, including
FAS, FASLG41,42, IL23R43, SIGLEC6 and SIGLEC12 (Supplementary
Table 7)44. For trachoma, we identified signals in ABCA1 and CXCR6,
whichmaybe important for thegrowthof the parasite andhost immune
response, respectively (Supplementary Table 7)45,46.
Designing medical genetics studies in Africa
To inform the design of genomic studies in Africa, we addressed the
following questions: (1) Howwell do current genotype arrays perform
inAfrican populations using existing reference panels for imputation?
(2) Can these genotype arrays and reference panels identify and fine-
mapassociation signals inpopulations acrossAfrica? (3)Canwe improve
imputation accuracy inAfrican populations using a newAfrican refer-
ence panel? and (4)What are themost cost-effective designs for large-
scale GWAS in Africa?
The 1000 Genomes Project phase I integrated panel provided rea-
sonably accurate imputation into the Illumina Omni 2.5M array in all
populations (Supplementary Note 10). However, imputation accuracy
was lower among Sotho, Zulu and Afro-Asiatic populations, possibly
reflecting poor representation of some African haplotypes (including
Khoe-San haplotypes) within the 1000 Genomes Project panel. These
findings suggest that improvements in imputationaccuracyacrossdiverse
population groups may require larger andmore diverse reference panels.
We assessed the reproducibility and potential for fine-mapping asso-
ciation signalswithinAfrica andglobally at several disease susceptibility
loci (Supplementary Methods, Supplementary Table 8 and Extended
Data Fig. 9). Current genotype arrays and imputation panels allowed
for identification of relevant association signals atmost loci across pop-
ulations inSSA,demonstrating that association signals are reproducible
across populations in SSA (Extended Data Fig. 9 and Supplementary
Figs7–18).Africanpopulations are likely toprovidebetter fine-mapping
resolution around the causal locus (Supplementary Table 8).We high-
light one example here: the sickle-cell anaemia locus (HBB)47, which is
under positive selection owing to the protection the sickle cells confer
against severe malaria. This locus showed marked heterogeneity in
association signals across populations, reflecting different linkage dis-
equilibrium patterns and allele frequencies among populations in SSA
(Supplementary Figs 9 and 10). This pattern is probably the result of
independent selection sweeps at this locus in different parts of Africa,
leading to differences in hitchhiking rare haplotypes that attained high
frequencies amongdifferent populations48. This suggests that these sig-
natures are recent and occurred during or after the Bantu expansion,
consistentwith thehypothesis that theadventof agriculture and increased
malaria transmissionmay have resulted in increased selection pressure49.
However, in contrast to previous reports47, we show that association
signals even at suchhighlydifferentiated loci canbecapturedwithdense
genotype data using existing reference panels for imputation, despite
individual population groups not being fully represented in these. This
suggests that, insteadof large-scale population-specific sequencing across
Africa, what is needed is a broad sequencing approach, targeted at cap-
turing widespread haplotype diversity.
To assess the utility of a larger and more diverse African reference
panel for imputation,wegenerated apanel integrating the1000Genomes
Project phase I and AGVPWGS panels (Supplementary Methods and
SupplementaryNote9).Using this integratedpanel,weobservedmarked
improvements in imputation accuracy across the whole range of the
allele frequency spectrum in specific populations poorly represented
by the 1000GenomesProject panel (Fig. 3 andSupplementaryNote 11).
These findings suggest that even commonhaplotypes in someSSApop-
ulations may not be sufficiently captured by existing panels, limiting
our power to examine associations of common variants with disease.
Importantly, given the specificity of the improvement in imputation
accuracy, we infer that targeted sequencing of divergent populations
representing a broad spectrum of haplotypes across Africa, including
HGandNorth/EastAfrican haplotypes, rather thanwidespread popu-
lation sequencing is likely to provide amore efficient strategy to improve
imputation accuracy and a practicable GWAS framework in Africa.
Wecompared the utility of existing chipdesigns (2.5MIllumina) and
ultralow-coverageWGSdesigns (0.53, 13, 23 coverage) to determine
the optimal design for African GWAS. Sensitivity for common varia-
tionwas.90%at all sequencingdepths (SupplementaryNote 12). Exam-
ining the effective sample size for a fixed budget50, we found the effective
sample size was greater for all ultralow-coverage WGS and chip array
designs compared with 43 WGS. When computational costs were
accounted for (Supplementary Note 12), the HumanOmni2.5M array
provided the greatest effective sample size supporting the development
and large-scale use of efficient genotype arrays in Africa, where these
have been underutilized.
We therefore sought to evaluate apotential chipdesign to tag common
variation across a wider range of African populations (Supplementary
Note 13). Importantly, we show that an array with one million genetic
variants could capture .80% of common variation (minor allele fre-
quency.5%) across the genome (Extended Data Fig. 10). These ana-
lyses suggest that designing a pan-African genotype array to effectively
capture common genetic variation across Africa is feasible, and could
greatly facilitate large-scale genomic studies in Africa.
Discussion
Themarked haplotype diversity within Africa has important implica-
tions for the design of large-scale medical genomics studies across the
region, as well as studies of population history and evolution. In this
context, the AGVP is a resource that will facilitate a broad range of
genomic studies in Africa and globally.
Although Africa is the most genetically diverse region in the world,
we provide evidence for relatively modest differentiation among pop-
ulations representing themajor sub-populations inSSA, consistentwith
recent population movement and expansion across the region begin-
ning around5,000 years ago—theBantuexpansion8.Although thehistory
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of the Bantu expansion is probably complex, assessments of population
admixture can provide new insights.We note historically complex and
regionally distinct admixture with multiple HG and Eurasian popula-
tions across SSA, including ancient HG and Eurasian ancestry inWest
andEastAfrica andmore recent complexHGadmixture in SouthAfrica.
Aswell as explaining genetic differentiation amongmodern populations
in SSA, these admixture patterns provide genetic evidence for early
back-to-Africa migrations, the possible existence of extant HG popu-
lations in western Africa—compatible with archaeological evidence15,
and patterns of gene flow consistentwith the Bantu expansion, includ-
ing genetic assimilation of populations resident across the region.
This admixture also has important implications for the assessment
of differentiation and positive selection in Africa. Accounting for these
elements,wehave identified loci under positive selection that are linked
withhypertension,malaria, andotherpathogens.This provides aproof-
of-concept for the abilityof geographicallywidespreadgeneticdatawithin
Africa to identify loci under selection related to diverse environments.
Our evidence for the broad transferability of genetic association sig-
nals and their statistical refinement has important implications for
medical genetic research in Africa. Importantly, we highlight that such
studies are feasible and can be enabled through the development of
more efficient genotype arrays and diverse WGS reference panels for
accurate imputation of common variation. In this context, we describe
a framework for a new pan-African genotype array that could directly
facilitate large-scale genomic studies in Africa.
A critical next step is the large-scale deep sequencing ofmultiple and
diversepopulations acrossAfrica,which shouldbe integratedwithancient
DNA data. This would enable us to identify and understand signals of
ancient admixture, patterns of historical population movements, and to
provide a comprehensive resource formedical genomic studies inAfrica.
Online Content Methods, along with any additional Extended Data display items
andSourceData, areavailable in theonlineversionof thepaper; referencesunique
to these sections appear only in the online paper.
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Extended Data Figure 1 | Allele sharing between sequenced populations in
theAGVP. a, The overlap of SNPs between 43WGSdata fromZulu, Ugandan
and Ethiopian individuals (subsampled to 100 samples each). b, The overlap
of novel variants (those not in the 1000 Genomes Project phase I integrated
call set, ‘1000G’) between the three populations. c, d, The allele frequency
spectra of variants in different portions of the Venn diagrams depicted in a and
b, respectively. There appear to be a large proportion of unshared (private)
variants in each population: between 10% and 23% of the total number of
variants in a given population. The proportion of novel variants was high, with
Ethiopia showing the greatest proportion of novel variation. Most of the novel
variation appears to be unshared and rare.
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ExtendedData Figure 2 | The first tenprincipal components for theAfrican
data set. PC1 shows a cline among several African populations, most likely to
represent Eurasian gene flow (n5 1,481). PC2 shows a clear separation
between West and South/East Africa. Subsequent PCs show more detailed
structure between, and within African populations.
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Extended Data Figure 3 | The first ten principal components for the global
data set, including populations from the 1000 Genomes Project. PC1 shows
a cline among several African populations extending towards European
populations, most likely to represent non-SSA gene flow (n5 2,864). PC2
shows a clear separation between European andAsian populations. Subsequent
PCs show more detailed structure between populations globally, and within
African populations. GBR, British in England and Scotland; ACB, African
Caribbeans in Barbados; ASW, Americans of African ancestry in southwestern
USA; CDX, Chinese Dai in Xishuangbanna, China; CEU, Utah residents with
Northern and Western European ancestry; CHB, Han Chinese in Beijing,
China; CHS, Southern Han Chinese; CLM, Colombians from Medellin,
Colombia; FIN, Finnish in Finland; GIH,Gujarati Indian fromHouston, Texas,
USA; IBS, Iberian population in Spain; JPT, Japanese in Tokyo, Japan; KHV,
Kinh in Ho Chi Minh City, Vietnam; MXL, Mexican ancestry from Los
Angeles, USA; PEL, Peruvians from Lima, Peru; PUR, Puerto Ricans from
Puerto Rico, and TSI, Toscani in Italy.
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Extended Data Figure 4 | The first ten principal components for the
global extended data set, including populations from the 1000 Genomes
Project, Human Genome Diversity Project, North African and Khoe-San
population groups. PC1 shows a cline among several African populations
extending towards European populations, most likely to represent non-SSA
gene flow (n5 3,202). PC2 shows a clear separation between European and
Asian populations. Subsequent principal components show more detailed
structure between populations globally, and within African populations.
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Extended Data Figure 5 | Projection of principal components to assess
admixture among African populations. a, The projection of principal
components calculated on YRI and CEU from the 1000 Genomes Project onto
the African populations. The AGVP populations are seen to fall on a cline
between YRI and CEU, with Ethiopian populations closest to CEU. This is
suggestive of Eurasian ancestry among these populations. b, The projection of
principal components calculated on YRI and Ju/’hoansi onto the AGVP and
other Khoe-San populations. The AGVP andKhoe-San populations are seen to
fall on a cline between YRI and Ju/’hoansi, with Zulu and Sotho leading the
cline among the AGVP populations. This is suggestive of HG gene flow among
these populations.
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Extended Data Figure 6 | ADMIXTURE clustering analysis for AGVP
samples combined with the 1000 Genomes Project, Human Genome
Diversity Project, North African and Khoe-San samples. Cluster K5 2
shows separation of European and African ancestry, with delineation of Asian
and Khoe-San ancestry in cluster K5 4. Subsequent clusters show separation
of East, West, North and South African ancestral components n5 3,202.
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Extended Data Figure 7 | Dating and source of admixture in the AGVP.
a, The time and most likely sources of admixture with means and 95%
confidence intervals for different AGVP populations estimated withMALDER
(see Supplementary Note 5). Circular markers with a line drawn around them
represent high-probability events, while those with no line around them
represent low-probability events. b, The time and most likely sources of
admixture estimated with MALDER for the same populations using
high-quality imputed data to improve resolution.
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Extended Data Figure 8 | Loci with marked allelic differentiation either
globally orwithinAfrica. The derived and ancestral alleles are depicted in blue
and red, respectively, for all loci. a, The global distribution of the non-
synonymous variant rs17047661 at the CR1 locus implicated in malaria
severity. This locus was noted to be among the most differentiated sites (in the
top 0.1%) between Europe and Africa. b, The global distribution of the
rs10216063 SNP at the AQP2 locus. The derived allele appears to be the major
allele among European populations in contrast to African populations. c, The
allele frequency distribution of rs10924081 at the ATP1A1 locus. Marked
differentiation is observed globally, with the derived allele noted to be themajor
allele among European populations. d, The global distribution of the risk allele
for the SNP rs1378940 in the CSK locus associated with hypertension. This
locus was found to be within the top 0.1% of differentiated loci within Africa,
and within the top 1% of differentiated loci globally. e, The allele frequency
distribution of the rs3213419 SNP at the HP locus. f, The allele frequency
distribution of the rs7313726 SNP at the CD163 locus. TheHP and CD163 are
among the top 0.1% of differentiated sites between malaria endemic and
non-endemic regions in Africa.
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Extended Data Figure 9 | The global distribution of biologically relevant
loci used for simulation of traits to examine reproducibility of signals across
AGVP populations. a, The frequency of the sickle-cell variant (rs334) in
different regions globally. The blue portion of each pie chart represents the
frequency of the causal allele A. b, The distribution of the SORT1 causal SNP
rs12740374, with the derived allele T depicted in blue. c–f, The distributions
of the APOL1 variant rs73885319, TCF7L2 variant rs7903146, the APOE
variant rs429358 and the PRDM9 variant rs6889665, respectively.
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Extended Data Figure 10 | The coverage obtained across the genome for
variants at different allele frequencies for a hypothetical African genotype
array with one million tagging variants. Different allele frequency bins are
depicted in different colours. The lines show the coverage that can be achieved
by imputation at different r2 thresholds. Coverage, here, is defined as the
proportion of variants within an allele frequency captured above a pre-defined
r2 threshold (along the x axis) after imputation. The solid lines represent the
coverage obtained with one million variants selected using the hybrid tagging
and imputation approach, while the broken lines represent the coverage
obtained by using a simple pairwise tagging approach to capture one million
tagging variants. The hybrid method improves the coverage obtained,
particularly for common variation. Coverage for common variants (.5%)
appears to be high at an r2 threshold of 0.8 and above, with .80% of these
variants accurately imputed.
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